ASEP Medical Holdings Inc.
SEPSF
$0.39
-$0.21-35.50%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.11% | -7.10% | 244.52% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.11% | -7.10% | 244.52% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -1.11% | -7.10% | 244.52% | -- | -- |
| SG&A Expenses | -59.88% | -17.90% | -56.72% | -51.69% | -20.53% |
| Depreciation & Amortization | -46.94% | -48.95% | -3.99% | -1.69% | 0.04% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -57.26% | -27.37% | -45.04% | -46.80% | -23.83% |
| Operating Income | 60.51% | 29.11% | 49.04% | 51.78% | 28.02% |
| Income Before Tax | 11.76% | 31.67% | -346.85% | 42.19% | 53.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.76% | 31.67% | -346.85% | 42.19% | 53.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -43.37% | -70.91% | 1,700.73% | -30.04% | -35.57% |
| Net Income | 5.75% | 22.84% | -172.39% | 45.18% | 55.61% |
| EBIT | 60.51% | 29.11% | 49.04% | 51.78% | 28.02% |
| EBITDA | 65.21% | 16.96% | 61.80% | 65.69% | 34.40% |
| EPS Basic | 34.08% | 29.46% | -136.48% | 54.38% | 65.19% |
| Normalized Basic EPS | 74.87% | 21.03% | 503.45% | 56.52% | 51.58% |
| EPS Diluted | 34.08% | 29.46% | -136.48% | 54.38% | 65.19% |
| Normalized Diluted EPS | 74.87% | 21.03% | 503.45% | 56.52% | 51.58% |
| Average Basic Shares Outstanding | 43.02% | 9.42% | 15.20% | 20.13% | 27.46% |
| Average Diluted Shares Outstanding | 43.02% | 9.42% | 15.20% | 20.13% | 27.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |